Improving healthcare infrastructure across several countries and
regions, coupled with availability of well-developed manufacturing
units, facilitates the growth of medical device businesses. The
changing attitude of patients towards treatment of generic diseases
has indicated a significant rise in preference for
self-administration devices such as auto-injectors. Promoting this
notion, auto-injectors continue to gain prominence not just as an
alternative route for drug delivery but also as point-of-care devices
in homecare settings. Future Market Insights recently published its
report on the global market for auto-injectors, which projects that
by the end of 2026, more than US$ 6,800 Mn worth of auto-injectors
will sold globally.
Report overview@
https://www.futuremarketinsights.com/reports/auto-injectors-market
In the report, titled “Auto-Injectors Market: Global Industry
Analysis and Opportunity Assessment, 2016-2026,” nearly
three-fourth of global auto-injector revenues have been estimated to
come from the US and Canada. While North America is being observed as
the largest market for auto-injectors in the world, auto-injector
sales will be relatively high in Western Europe as well. And,
majority of auto-injectors are expected to be distributed through
online pharmacies. Online pharmacies as a distribution channel will
register the fastest revenue growth at 18% CAGR, while retail
pharmacies will be procuring one-fourth of global market value by the
end of 2026.
The global market for auto-injectors is projected to expand
aggressively, and the report draws this forecast from identifying the
most direct, impactful factors that drive the demand for
auto-injectors. Firstly, the demand for auto-injectors is expected to
keep soaring on the account of high adoption of self-injection
practices by patients. Doctors, as well, are prompting patients to
take up self-administration devices such as auto-injectors in order
to fulfil their prescribed medication dosages through invasive yet
safe administration routes.
Along with that, the global demand for auto-injectors is also
expected to be driven by growing development of novel drug delivery
systems. Manufacturers of medical devices are collaborating with
clinical scientists in order to pave way for next-gen tools in drug
administration. In the years to come, the global auto-injectors
market is anticipated to garner surplus demand, particularly for
prefilled auto-injectors. In 2017 and beyond, more than 92% of global
auto-injectors revenues will be emanating from sales of prefilled
auto-injectors. Fillable auto-injectors, on the other hand, will
incur a downtick in terms of global revenue share over the latter
half of forecast period.
Request to sample report@
https://www.futuremarketinsights.com/reports/sample/rep-gb-1642
Another factor that is inducing growth in demand for auto-injectors
is the prevalence of multiple sclerosis and anaphylaxis. Notable
disease monitoring associations from across the globe are predicting
that these disorders are less likely to cease their occurrence rate
among geriatric populations, which is incidentally boosting the
demand for auto-injectors. In 2016, anaphylaxis as a disease
indication accounted for an estimated US$ 1,500 Mn of global
auto-injector revenues. Through 2026, almost nine out of ten
auto-injectors sold globally are likely to be used for treating
anaphylaxis. Meanwhile, auto-injectors sold for treatment of multiple
sclerosis will register a marginal rise through the forecast period.
And, revenues amassed from sales of auto-injectors for rheumatoid
arthritis are expected to showcase highest CAGR of 18.3%.
Parallel to their rising demand, the global supply of auto-injectors
is also expected to propel by the end of 2026. Increased development
of biologics, their use in production of advanced drug delivery
devices, reduction of manufacturing prices, and additional
cost-savings conferred by technological advancements, are all
collectively bolstering the global production of auto-injectors. The
report has profiled leading players in the global auto-injectors
market, which include Amgen Inc., Novartis AG, Sanofi, Pfizer, Inc.,
Becton, Dickson and Company, Mylan NV, Bayer AG, Eli Lily and
Company, Janssen Global Services, LLC, and Antares Pharma, Inc.
Request report toc@
https://www.futuremarketinsights.com/reports/auto-injectors-market/toc
ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and
consulting firm. We deliver syndicated research reports, custom
research reports and consulting services, which are personalized in
nature. FMI delivers a complete packaged solution, which combines
current market intelligence, statistical anecdotes, technology
inputs, valuable growth insights, an aerial view of the competitive
framework, and future market trends.
CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website:
www.futuremarketinsights.com
No comments:
Post a Comment